Dopaminergic medication exaggerates the experience of voluntary motor control in Parkinson's disease

被引:0
|
作者
Moore, J. W.
Susanne, S. A.
Schwingenschuh, P.
Moretto, G.
Bhatia, K. P.
Haggard, P.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S305 / S305
页数:1
相关论文
共 50 条
  • [21] Dopaminergic medication affects choice bias in Parkinson's disease
    van Nuland, A. J. M.
    Helmich, R. C. G.
    Dirkx, M.
    Zach, H.
    Bloem, B. R.
    Toni, I.
    Cools, R.
    den Ouden, H. E. M.
    MOVEMENT DISORDERS, 2016, 31 : S423 - S424
  • [22] EFFECT OF DOPAMINERGIC MEDICATION ON RISK PREFERENCE IN PARKINSON'S DISEASE
    Mandali, Alekhya
    Chaudhuri, Ray
    Rizos, Alexandra
    Voon, Valerie
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 : A20 - A21
  • [23] Dopaminergic Medication Effects on the Speech of Individuals with Parkinson's Disease
    Spencer, Kristie A.
    Morgan, Kelly W.
    Blond, Emily
    JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY, 2009, 17 (03) : 125 - 144
  • [24] The effect of dopaminergic medication on conflict adaptation in Parkinson's disease
    Ruitenberg, Marit F. L.
    Abrahamse, Elger L.
    Santens, Patrick
    Notebaert, Wim
    JOURNAL OF NEUROPSYCHOLOGY, 2019, 13 (01) : 121 - 135
  • [25] The influence of dopaminergic medication on balance automaticity in Parkinson's disease
    Workman, Craig D.
    Thrasher, T. Adam
    GAIT & POSTURE, 2019, 70 : 98 - 103
  • [26] The influence of dopaminergic medication on gait automaticity in Parkinson's disease
    Workman, Craig D.
    Thrasher, T. Adam
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 65 : 71 - 76
  • [27] In Parkinson's disease patients hand dexterity and UPDRS motor scores respond differently to dopaminergic medication
    Filipovic, S.
    Kacar, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 468 - 469
  • [28] History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease
    Kacar, A.
    Filipovic, S. R.
    Kresojevic, N.
    Milanovic, S. D.
    Ljubisavljevic, M.
    Kostic, V. S.
    Rothwell, J. C.
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (04) : 697 - 707
  • [29] Dopaminergic Medication Improves Cognitive Control Under Low Cognitive Demand in Parkinson's Disease
    Williams, Isobel A.
    Obeso, Ignacio
    Jahanshahi, Marjan
    NEUROPSYCHOLOGY, 2020, 34 (05) : 551 - 559
  • [30] The role of dopaminergic medication doses in impulse control disorders (ICD) in Parkinson's disease (PD)
    Jimenez-Shahed, J.
    Baker, K.
    Davidson, A.
    Jankovic, J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S82 - S83